Phibro Animal Health (PAHC) has seen impressive momentum in the past year, with its shares soaring 82.8%. It has significantly outperformed the 9.6% rise of the industry and the S&P 500 Composite’s 26.7% gain.Presently carrying a Zacks Rank #3 (Hold), the diversified animal health and mineral nutrition company is benefiting from the remarkable performance of the Animal Health business. Phibro is well-positioned to pursue global growth opportunities, while the resilience of the Mineral Nutrition arm is highl ...

Phibro Animal Health Corporation’s (PAHC) growth in the fiscal first quarter of 2025 is backed by sustained improvement in the Animal Health business. The company’s focus on advancing vaccine technologies instills optimism. A rebound of Mineral Nutrition and Performance Product businesses seems encouraging. Yet, adverse macroeconomic impacts are a concern for Phibro’s operations.In the past year, this Zacks Rank #2 (Buy) company’s shares have rallied 107.9% compared with the industry’s 20.9% growth and the ...

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a growth stock that can live up to its true potential can be a tough task.In addition to volatility, these stocks carry above-average risk by their very nature. Also, one could end up losing from a stock whose growth story is actually over or nearing its end.However, the Zacks Growth Style Score (part of the Zacks Style Scores sy ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both. The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor. Zacks Premium includes access to the Zacks Style ...

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a great growth stock is not easy at all.That's because, these stocks usually carry above-average risk and volatility. In fact, betting on a stock for which the growth story is actually over or nearing its end could lead to significant loss.However, the task of finding cutting-edge growth stocks is made easy with the help ...

Have you been paying attention to shares of Phibro Animal Health (PAHC) ? Shares have been on the move with the stock up 5.2% over the past month. The stock hit a new 52-week high of $25.61 in the previous session. Phibro Animal Health has gained 120.6% since the start of the year compared to the 4.7% move for the Zacks Medical sector and the 15% return for the Zacks Medical - Products industry.What's Driving the Outperformance?The stock has a great record of positive earnings surprises, as it hasn't missed ...

Have you evaluated the performance of Phibro Animal Health's (PAHC) international operations for the quarter ending September 2024? Given the extensive global presence of this maker of animal health products and nutritional supplements, analyzing the patterns in international revenues is crucial for understanding its financial strength and potential for growth.The global economy today is deeply interlinked, making a company's engagement with international markets a critical factor in determining its financi ...

Phibro Animal Health Corporation (NASDAQ:PAHC) Q1 2025 Earnings Conference Call November 7, 2024 9:00 AM ET Company Participants Glenn David - Chief Financial Officer Jack Bendheim - Chairman-Board of Directors, President & Chief Executive Officer Daniel Bendheim - Director & Executive Vice President-Corporate Strategy Larry Miller - Chief Operating Officer Conference Call Participants Ekaterina Knyazkova - JPMorgan Michael Ryskin - Bank of America Navann Ty - BNP Paribas Operator Hello, and thank you for s ...

Phibro Animal Health Corporation Webcast and Conference Call November 7, 2024 U.S. toll-free +1.888.330.2022 International toll +1.365.977.0051 Conference ID: 3927884 Financial Results Fiscal Year 2025 First Quarter Ended September 30, 2024 November 7, 2024 Webcast and Conference Call Important Information Cautionary Statement Regarding Forward-Looking Statements This communication contains forward-looking statements that are subject to risks and uncertainties, including with respect to any future debt and ...

Phibro Animal Health (PAHC) delivered adjusted earnings per share (EPS) of 35 cents in the first quarter of fiscal 2025 compared with 14 cents in the year-ago quarter. The bottom line beat the Zacks Consensus Estimate by 52.2%.Without adjustments, the GAAP EPS in the quarter was 17 cents compared to a loss of 20 cents in the prior-year period.Find the latest EPS estimates and surprises on Zacks Earnings Calendar.Following the announcement, PAHC shares rose nearly 8% in the after-hours trading yesterday.  PA ...